Who Supplies Vinblastine? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Vinblastine exports, with 140+ registered manufacturers shipping to buyers across 96+ countries — yet a handful of companies dominate the shipments. NAPROD LIFE SCIENCES PRIVATE LIMITED holds the largest share at 12.8% (export value: $96.4K). Close behind, SP ACCURE LABS PRIVATE LIMITED (11.7%, $87.6K). ADVANOV PHARMA PRIVATE LIMITED (6.1%, $45.7K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Vinblastine? Top Manufacturers & Their Buyers
Flow of Vinblastine from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Vinblastine Supplier Network — Key Market Intelligence
The Vinblastine export market from India is led by NAPROD LIFE SCIENCES PRIVATE LIMITED, which alone commands a 12.8% share, shipping $96.4K worth of product across 5 shipments. The second-largest exporter, SP ACCURE LABS PRIVATE LIMITED, contributes $87.6K (11.7%) to the overall market. Combined, the top two suppliers alone account for 24.5% of all Vinblastine exports, indicating a relatively concentrated supply base.
Across all 140 tracked manufacturers, the total Vinblastine export value stands at $750.1K from 573 shipments. The market average shipment value is $1.3K. The single largest buyer relationship in terms of trade value is THE GOVERNMENT PHARM, receiving $58.3K worth of product.
The combined buyer network spans 16 named purchasing companies, including THE GOVERNMENT PHARM, AL PHARMA S,A,S / DE, PLANET PHARMACEUTICA, HIRAD PHRAMED, HIRAD PHARMED UNIT and 11 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1NAPROD LIFE SCIENCES PRIVATE LIMITED
NAPROD LIFE SCIENCES PRIVATE LIMITED is the first-largest Vinblastine exporter from India, with a market share of 12.8% and a total export value of $96.4K across 5 shipments. Their average shipment value of $19.3K is above the market average of $1.3K, suggesting premium or bulk contract pricing.
NAPROD LIFE SCIENCES PRIVATE LIMITED serves 3 named buyers in our database. THE GOVERNMENT PHARM is the dominant customer, accounting for 60.5% of this supplier's tracked business. Top customers include:
• THE GOVERNMENT PHARM — $58.3K across 3 shipments (60.5% of this supplier's total exports)
• AL PHARMA S,A,S / DE — $36.0K across 2 shipments (37.3% of this supplier's total exports)
• PLANET PHARMACEUTICA — $2.1K across 0 shipments (2.2% of this supplier's total exports)
Key Insight: NAPROD LIFE SCIENCES PRIVATE LIMITED's per-shipment value of $19.3K is 1373% above the market average of $1.3K, consistent with large-order contracts or value-added formulations.
2SP ACCURE LABS PRIVATE LIMITED
SP ACCURE LABS PRIVATE LIMITED is the second-largest Vinblastine exporter from India, with a market share of 11.7% and a total export value of $87.6K across 11 shipments. Their average shipment value of $8.0K is above the market average of $1.3K, suggesting premium or bulk contract pricing.
SP ACCURE LABS PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• HIRAD PHRAMED — $42.4K across 5 shipments (48.5% of this supplier's total exports)
• HIRAD PHARMED UNIT — $27.5K across 3 shipments (31.4% of this supplier's total exports)
• SOCIETE DE THERAPEUT — $9.1K across 1 shipments (10.4% of this supplier's total exports)
• PHARMACIE,CENTRALE D — $4.5K across 1 shipments (5.1% of this supplier's total exports)
• PHARMACIE,CENTRALE D — $4.0K across 1 shipments (4.6% of this supplier's total exports)
Key Insight: SP ACCURE LABS PRIVATE LIMITED's per-shipment value of $8.0K is 508% above the market average of $1.3K, consistent with large-order contracts or value-added formulations.
3ADVANOV PHARMA PRIVATE LIMITED
ADVANOV PHARMA PRIVATE LIMITED is the third-largest Vinblastine exporter from India, with a market share of 6.1% and a total export value of $45.7K across 5 shipments. Their average shipment value of $9.1K is above the market average of $1.3K, suggesting premium or bulk contract pricing.
ADVANOV PHARMA PRIVATE LIMITED serves 3 named buyers in our database. LABORATORIOS KAMPAR S.A. is the dominant customer, accounting for 58.3% of this supplier's tracked business. Top customers include:
• LABORATORIOS KAMPAR S.A. — $26.6K across 3 shipments (58.3% of this supplier's total exports)
• LABORATORIOS KAMPAR S.A. — $17.5K across 2 shipments (38.3% of this supplier's total exports)
• PLANET PHARMACEUTICA — $1.6K across 0 shipments (3.5% of this supplier's total exports)
Key Insight: ADVANOV PHARMA PRIVATE LIMITED's per-shipment value of $9.1K is 598% above the market average of $1.3K, consistent with large-order contracts or value-added formulations.
4AXA PARENTERALS LIMITED
AXA PARENTERALS LIMITED is the fourth-largest Vinblastine exporter from India, with a market share of 4.9% and a total export value of $37.1K across 5 shipments. Their average shipment value of $7.4K is above the market average of $1.3K, suggesting premium or bulk contract pricing.
AXA PARENTERALS LIMITED serves 1 named buyer in our database. TO THE ORDER OF PURC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF PURC — $37.1K across 5 shipments (100.0% of this supplier's total exports)
Key Insight: AXA PARENTERALS LIMITED's per-shipment value of $7.4K is 467% above the market average of $1.3K, consistent with large-order contracts or value-added formulations.
5KWALITY PHARMACEUTICALS LIMITED
KWALITY PHARMACEUTICALS LIMITED is the fifth-largest Vinblastine exporter from India, with a market share of 4.6% and a total export value of $34.7K across 6 shipments. Their average shipment value of $5.8K is above the market average of $1.3K, suggesting premium or bulk contract pricing.
KWALITY PHARMACEUTICALS LIMITED serves 4 named buyers in our database. GLORINCOR PHARMACEUTICALS OOO is the dominant customer, accounting for 57.8% of this supplier's tracked business. Top customers include:
• GLORINCOR PHARMACEUTICALS OOO — $20.0K across 3 shipments (57.8% of this supplier's total exports)
• GLORINCOR PHARMACEUTICALS OOO — $8.6K across 1 shipments (24.7% of this supplier's total exports)
• DITA ESTFARM LLC — $3.8K across 1 shipments (10.9% of this supplier's total exports)
• PHARMA PLUS MALI, S. — $2.3K across 0 shipments (6.6% of this supplier's total exports)
Key Insight: KWALITY PHARMACEUTICALS LIMITED's per-shipment value of $5.8K is 341% above the market average of $1.3K, consistent with large-order contracts or value-added formulations.
6UNITED BIOTECH PRIVATE LIMITED
UNITED BIOTECH PRIVATE LIMITED is the fifth-largest Vinblastine exporter from India, with a market share of 4.0% and a total export value of $30.0K across 29 shipments. Their average shipment value of $1.0K is below the market average of $1.3K, reflecting a high-volume, competitive pricing strategy.
UNITED BIOTECH PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• PEOPLE'S BANK — $10.7K across 10 shipments (35.9% of this supplier's total exports)
• PHARMACEUTICAL DISTOLOZA S.A. — $6.6K across 6 shipments (22.0% of this supplier's total exports)
• CREDIT AGRICOLE DU M — $4.8K across 5 shipments (15.9% of this supplier's total exports)
• HATTON NATIONAL BANK — $4.3K across 4 shipments (14.3% of this supplier's total exports)
• PHARMACIE NATIONALE — $3.6K across 3 shipments (11.9% of this supplier's total exports)
Key Insight: UNITED BIOTECH PRIVATE LIMITED operates with high shipment frequency (29 shipments) at a per-shipment value of $1.0K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Vinblastine Flows
Once Vinblastine leaves the manufacturing plants of companies like NAPROD LIFE SCIENCES PRIVATE LIMITED and SP ACCURE LABS PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $750.1K. Colombia absorbs the largest share at 9.6% ($72.2K), followed by Iran (9.3%) and Poland (8.0%).
This geographic spread reflects Vinblastine's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Vinblastine Go? Top Importing Countries & Their Buyers
Trade flow of Vinblastine exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Colombia
Colombia ranks as the first-largest destination for Vinblastine imports from India, with a total trade value of $72.2K across 0 shipments — representing a 9.6% share of all Vinblastine exports. The average shipment value of $72.2K is above the global average of $1.3K, indicating high-value procurement contracts or branded formulations.
Key Insight: Colombia's per-shipment average of $72.2K (5413% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Colombia is a key market for Vinblastine imports from India.
2Iran
Iran ranks as the second-largest destination for Vinblastine imports from India, with a total trade value of $70.0K across 2 shipments — representing a 9.3% share of all Vinblastine exports. The average shipment value of $35.0K is above the global average of $1.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Vinblastine importers in Iran: HIRAD PHRAMED is the largest buyer, accounting for 60.7% ($42.4K) of this market's total imports.
• HIRAD PHRAMED — $42.4K (60.7% of Iran's total)
Key Insight: Iran's per-shipment average of $35.0K (2572% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Iran is a key market for Vinblastine imports from India.
3Poland
Poland ranks as the third-largest destination for Vinblastine imports from India, with a total trade value of $59.7K across 4 shipments — representing a 8.0% share of all Vinblastine exports. The average shipment value of $14.9K is above the global average of $1.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Vinblastine importers in Poland: EXP CODE is the largest buyer, accounting for 48.4% ($28.9K) of this market's total imports.
• EXP CODE — $28.9K (48.4% of Poland's total)
Key Insight: Poland's per-shipment average of $14.9K (1041% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Poland is a key market for Vinblastine imports from India.
4Thailand
Thailand ranks as the fourth-largest destination for Vinblastine imports from India, with a total trade value of $59.3K across 0 shipments — representing a 7.9% share of all Vinblastine exports. The average shipment value of $59.3K is above the global average of $1.3K, indicating high-value procurement contracts or branded formulations.
Key Insight: Thailand's per-shipment average of $59.3K (4427% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Thailand is a key market for Vinblastine imports from India.
5Venezuela
Venezuela ranks as the fifth-largest destination for Vinblastine imports from India, with a total trade value of $48.1K across 0 shipments — representing a 6.4% share of all Vinblastine exports. The average shipment value of $48.1K is above the global average of $1.3K, indicating high-value procurement contracts or branded formulations.
Key Insight: Venezuela's per-shipment average of $48.1K (3577% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Venezuela is a key market for Vinblastine imports from India.
People Also Ask — Vinblastine Supplier & Trade Network
Who are the top suppliers of Vinblastine from India?+
Which companies buy Vinblastine from Indian manufacturers?+
Where does Vinblastine exported from India go?+
What is the market share of the top Vinblastine supplier from India?+
What is the average shipment value for Vinblastine exports from India?+
Is Vinblastine manufactured in India and exported globally?+
Which country imports the most Vinblastine from India?+
Who are the buyers of Vinblastine in Iran?+
How concentrated is the Vinblastine supplier market in India?+
How do I find verified buyers for Vinblastine in specific countries?+
Vinblastine Trade Network — Key Takeaways
- 1NAPROD LIFE SCIENCES PRIVATE LIMITED is India's dominant Vinblastine exporter with a 12.8% market share and $96.4K in total exports — making it the single most important sourcing entity in this market.
- 2The top 140 suppliers collectively account for 44.2% of all tracked Vinblastine exports, with a combined trade value of $750.1K.
- 3Colombia is the largest destination market, absorbing 9.6% of India's Vinblastine exports ($72.2K). Iran (9.3%) and Poland (8.0%) follow.
- 4With 573 total shipments averaging $1.3K each, the Vinblastine export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include THE GOVERNMENT PHARM, AL PHARMA S,A,S / DE, HIRAD PHRAMED, HIRAD PHARMED UNIT — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 3 customers
6 suppliers → 96 countries
Network value: $750.1K
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vinblastine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Vinblastine.
- 2.Flow Mapping: 140 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 573 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 96 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
573 Verified Shipments
140 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists